New Indication Discovery Research Service for Drug Development Companies to Strengthen their Pipeline

IndiSwitch from VLife Sciences Technologies Pvt. Lt is a new indication discovery research service and helps companies to fully exploit protected IP by discovering new indications for approved molecules by design thus enabling repurposing of those molecules.

VLife brings 2 layered approach with New Indication service:
• Layer 1: Identifying benefits of existing molecule by means of exploring new indication for pursuing it in clinical trial
• Layer 2: Identifying and comparing Positive controls by understanding molecule’s mechanism of action

This service is delivered through cutting edge VLifeRVHTS technology for exploring potential New Indications for a given molecule or a set of molecules. Through VLife offering, the client accesses not only the power of VLifeRVHTS technology platform but also a highly knowledgeable scientific team having cumulative experience of over 300 man years in computational research. VLife IndiSwitch service has already delivered 7 new indication discoveries; several of these are in clinical trials with VLife clients.

VLifeRVHTS technology platform benefits over conventional research approaches:
• Study of molecule’s likely usefulness against targets for which Bio-assays are not available.
• Molecule’s interaction with the targets whose crystal structures are yet to be elucidated (in the case when model is available)